{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
desonide
to a specific field?
Status:
Investigational
Source:
INN:adalimumab fosimdesonide [INN]
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
ANDA208836
(2017)
Source URL:
First approved in 1972
Source:
NDA017010
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Desonide is a topical glucocorticoid which was approved by FDA for the treatment of such conditions as eczema, psoriasis, atopic dermatitis, etc. The exact mechanism of drug action is unknown.
Status:
US Approved Rx
(2017)
Source:
ANDA208836
(2017)
Source URL:
First approved in 1972
Source:
NDA017010
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Desonide is a topical glucocorticoid which was approved by FDA for the treatment of such conditions as eczema, psoriasis, atopic dermatitis, etc. The exact mechanism of drug action is unknown.
Status:
US Approved Rx
(2017)
Source:
ANDA208836
(2017)
Source URL:
First approved in 1972
Source:
NDA017010
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Desonide is a topical glucocorticoid which was approved by FDA for the treatment of such conditions as eczema, psoriasis, atopic dermatitis, etc. The exact mechanism of drug action is unknown.
